Ian Herriott, BS

Manager of Sequencing Technologies
Day Zero Diagnostics

Disclosure: Day Zero Diagnostics (Individual(s) Involved: Self): Employee, Shareholder

Presentation(s):

• 152 - blood2bac: Species ID and AMR Prediction of Bacterial Pathogens at Low Concentrations in Blood Using a Rapid Ultra-high Enrichment Process and Nanopore Sequencing

  Oral Abstract

• 153 - pilot Study of a Novel Whole-genome Sequencing Based Rapid Bacterial Identification Assay in Patients with Bacteremia

  Oral Abstract